Literature DB >> 26788207

MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.

Yang Yang1, Su'e Chang1, Zhenghao Zhao1, N I Hou1, Kang He1, Xiaofei Wang1, Ling Gao1, Lumin Wang1, Donghui Cai1, B O Guo1, Dongdong Tong1, Tusheng Song1, Chen Huang2.   

Abstract

MicroRNAs (miRNAs) are important gene regulators that participate in tumorigenesis. Previous studies have implicated that miR-214 is a tumor suppressor that is capable of inhibiting human hepatocellular carcinoma (HCC) cell growth. However, the mechanism by which miR-214 suppresses tumor development remains unknown. In the present study, miR-214 was observed to suppress tumor proliferation by directly targeting E2F transcription factor 3 (E2F3) in HCC cells. Colony formation, cell cycle and proliferation assays were employed to study the tumor suppressor role of miR-214 in cell proliferation. In addition, western blotting and dual-luciferase reporter assays were used to evaluate whether E2F3 was a target of miR-214. The results of these analyses revealed that E2F3 was a novel target of miR-214. Furthermore, enhanced expression of miR-214 or silencing of E2F3 inhibited the proliferation of HCC SMMC-7721 cells. These findings suggest that miR-214 suppresses HCC growth by targeting E2F3, and may provide a novel approach for the treatment of human HCC.

Entities:  

Keywords:  E2F3; hepatocellular carcinoma; miR-214; proliferation

Year:  2015        PMID: 26788207      PMCID: PMC4665883          DOI: 10.3892/ol.2015.3745

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Developmental biology. Encountering microRNAs in cell fate signaling.

Authors:  Xantha Karp; Victor Ambros
Journal:  Science       Date:  2005-11-25       Impact factor: 47.728

Review 2.  MicroRNA function in animal development.

Authors:  Erno Wienholds; Ronald H A Plasterk
Journal:  FEBS Lett       Date:  2005-08-10       Impact factor: 4.124

3.  MACC 1 as a marker for vascular invasive hepatocellular carcinoma.

Authors:  Atsushi Shirahata; Wu Fan; Kazuma Sakuraba; Kazuaki Yokomizo; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

4.  Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

Authors:  Heidi Schwarzenbach; Karin Milde-Langosch; Bettina Steinbach; Volkmar Müller; Klaus Pantel
Journal:  Breast Cancer Res Treat       Date:  2012-02-19       Impact factor: 4.872

Review 5.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

6.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

7.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

8.  Robustness and backbone motif of a cancer network regulated by miR-17-92 cluster during the G1/S transition.

Authors:  Lijian Yang; Yan Meng; Chun Bao; Wangheng Liu; Chengzhang Ma; Anbang Li; Zhan Xuan; Ge Shan; Ya Jia
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.

Authors:  Lumin Wang; Jiayi Yao; Xin Shi; Lili Hu; Zongfang Li; Tusheng Song; Chen Huang
Journal:  BMC Cancer       Date:  2013-10-02       Impact factor: 4.430

Review 10.  Epigenetic alteration and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Front Genet       Date:  2013-12-03       Impact factor: 4.599

View more
  9 in total

1.  miR-214 Modulates the Growth and Migration of Oral Cancer before and after Chemotherapy through Mediating ULK1.

Authors:  Yongtao Yang; Xiaolan Sun; Minghua Li; Limei Li; Shanshan Wang; Yaomin Zhu
Journal:  J Immunol Res       Date:  2022-06-02       Impact factor: 4.493

2.  MiRNA-610 acts as a tumour suppressor to depress the cisplatin resistance in hepatocellular carcinoma through targeted silencing of hepatoma-derived growth factor.

Authors:  Yongqing Xu; Helin Wang; Weike Gao
Journal:  Arch Med Sci       Date:  2019-09-12       Impact factor: 3.318

3.  miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer.

Authors:  Huiqin Yang; Lixia Wang; Xiaoli Tang; Wenmei Bai
Journal:  Oncol Lett       Date:  2017-10-17       Impact factor: 2.967

4.  Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.

Authors:  Qin Tang; Qi Wang; Qiong Zhang; Sheng-Yan Lin; Yanhong Zhu; Xiangliang Yang; An-Yuan Guo
Journal:  BMC Cancer       Date:  2017-12-18       Impact factor: 4.430

Review 5.  MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers.

Authors:  Yanping Gao; Bing Feng; Lu Lu; Siqi Han; Xiaoyuan Chu; Longbang Chen; Rui Wang
Journal:  Oncotarget       Date:  2017-04-21

6.  Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.

Authors:  Yan-Lin Huang; Gang Ning; Lu-Biao Chen; Yi-Fan Lian; Yu-Rong Gu; Jia-Liang Wang; Dong-Mei Chen; Huan Wei; Yue-Hua Huang
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

Review 7.  MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.

Authors:  Matthew L Potter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

8.  LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.

Authors:  Meixiao Zhan; Ke He; Jing Xiao; Fei Liu; Haihe Wang; Zhenglin Xia; Xiaopeng Duan; Rui Huang; Yong Li; Xu He; Hua Yin; Guoan Xiang; Ligong Lu
Journal:  J Cell Mol Med       Date:  2018-05-15       Impact factor: 5.295

9.  6mer Seed Toxicity in Viral microRNAs.

Authors:  Andrea E Murmann; Elizabeth T Bartom; Matthew J Schipma; Jacob Vilker; Siquan Chen; Marcus E Peter
Journal:  iScience       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.